Fingerpaint Marketing's target audience consists primarily of companies operating within the life sciences sector. This encompasses pharmaceutical companies (both large multinational corporations and smaller specialty pharma), biotechnology firms (especially those developing novel therapies or in the clinical trial phases), and medical device manufacturers. Given their focus on scientific communications and deep therapeutic area expertise, they likely target companies at various stages of their product lifecycle, from pre-commercialization and launch planning to established brands seeking revitalization or lifecycle management. They are particularly attractive to companies dealing with complex scientific information, orphan drugs, rare diseases, or highly specialized therapies that require nuanced communication strategies. The agency's expertise in navigating regulatory environments (e.g., FDA, EMA) makes them a strong partner for companies launching new drugs or devices. Beyond the core life sciences industries, there might be an ancillary target of healthcare providers, although their direct client base appears to be B2B within the pharma/biotech/med device ecosystem.